Upregulation of c-Jun expression by drug or CAR-T cell therapy effectively stabilized NFAT: AP-1 cooperation, which inhibited the NFAT-dependent exhaustion program, expanded Tpex and greatly enhanced anti-tumor immunity (12, 57, 58). Here, JUN is linked to neoplasm.